
RETATRUT
An innovative approach to weight reduction and metabolic control
RETATRUT is a next-generation injectable peptide developed to support recovery, metabolism, and physical condition during periods of increased physical load.
When RETATRUT is used:
after injuries or intensive training
in cases of overweight or obesity
during periods focused on reducing body fat
in insulin resistance and disorders of carbohydrate metabolism
for appetite control and regulation of eating behavior
in metabolic syndrome or reduced insulin sensitivity
Key properties:
support of muscle and connective tissue recovery
involvement in the regulation of metabolic processes
delayed gastric emptying
reduction of appetite and caloric intake
promotion of recovery after physical exertion
Effects during treatment:
reduction of body weight due to loss of adipose tissue
improved control of blood glucose levels
increased insulin sensitivity
reduced appetite and food cravings
influence on the body’s energy balance
Pharmaceutical quality:
synthetic peptide with a clearly defined molecular structure
high degree of purification
stable pharmaceutical dosage form
manufactured in accordance with GMP standards
Dosage form:
Lyophilized powder of white or almost white color for preparation of a solution for injection.
After reconstitution, a clear, colorless solution without visible particles is obtained.
Packaging: 1 vial — 16 mg.
Method of administration:
The product is intended for subcutaneous administration once weekly.
The dosage is titrated gradually:
initiation with the minimum dose
stepwise dose escalation at intervals of no less than 4 weeks
the maintenance dose is determined by a physician based on efficacy and tolerability
Storage conditions:
Store at a temperature of 2–8 °C, protected from light.
Do not freeze.
Follow the storage conditions specified in the manufacturer’s instructions.
Manufacturer:
American Pharmaceutical, Inc.
USA, Ohio
Important:
This product is a prescription medicinal product.
Use is permitted exclusively as prescribed by a physician after evaluation of indications and contraindications.




